Potential of the Polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals

Applied and Environmental Microbiology

Volumn 71, Issue 4, 2005, Pages 1836-1842

  O'Flaherty, S ^a,b   Ross, R P ^a,c   Meaney, W ^a   Fitzgerald, G F ^b,c   Elbreki, M F ^d   Coffey, A ^d  

^a ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d Munster Technological University   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; BISMUTH; DRUG PRODUCTS; MICROBIOLOGY;

ANTI-STAPHYLOCOCCUS BACTERIOPHAGE; DRUG-RESISTANCE; STAPHYLOCOCCUS AUREUS;

BACTERIOPHAGES;

METICILLIN; TEICOPLANIN; VANCOMYCIN;

MICROBIOLOGY;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; HAND WASHING; HOSPITAL; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; SKIN; STAPHYLOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; HANDWASHING; HOSPITALS; HUMANS; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

EID: 17444380108     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.71.4.1836-1842.2005     Document Type: Article

References (38)

1. Ackermann, H. W., and M. S. DuBow. 1987. Viruses of prokaryotes, vol. 1. CRC Press, Boca Raton, Fla.
2. Alisky, J., K. Iczkowski, A. Rapoport, and N. Troitsky. 1998. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:5-15.
3. Breithaupt, H. 1999. The new antibiotics. Nat. Biotechnol. 17:1165-1169.
4. Burnet, F. M., and D. Lush. 1935. The staphylococcal bacteriophages. J. Pathol. Bacteriol. 40:455-469.
5. Carlton, R. M. 1999. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. 47:267-274.
6. Cotter, L., M. Daly, P. Greer, B. Cryan, and S. Fanning. 1998. Motif-dependent DNA analysis of a methicillin-resistant Staphylococcus aureus collection. Br. J. Biomed. Sci. 55:99-106.
7. Deshpande, L. M., T. R. Fritsche, and R. N. Jones. 2004. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 49:231-236.
8. Duckworth, D. H., and P. A. Gulig. 2002. Bacteriophages: potential treatment for bacterial infections. BioDrugs 16:57-62.
9. Fischetti, V. A. 2001. Phage antibacterials make a comeback. Nat. Biotechnol. 19:734-735.
10. Fitzgerald, J. R., W. J. Meaney, P. J. Hartigan, C. J. Smyth, and V. Kapur. 1997. Fine-structure molecular epidemiological analysis of Staphylococcus aureus recovered from cows. Epidemiol. Infect. 119:261-269.
11. Gratia, A., and M. De Namur. 1922. Individualite des principes lytiques staphylococciques de provenances differentes. C. R. Soc. Biol. 87:364-366.
12. Harley, J. P. 2004. The effects of chemical agents on bacteria. II. Antimicrobial agents (Kirby-Bauer method). McGraw-Hill, New York, N.Y.
13. Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155.
14. Hiramatsu, K., L. Cui, M. Kuroda, and T. Ito. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9:486-493.
15. Hotchin, J. E. 1954. The purification and electron microscopical examination of the structure of staphylococcal bacteriophage K. J. Gen. Microbiol. 10:250-260.
16. Hotchin, J. E. 1951. Staphylococcus aureus and Staphylococcus K phage. J. Gen. Microbiol. 5:609-618.
17. Hotchin, J. E., I. M. Dawson, and W. J. Elford. 1952. The use of empty bacterial membranes in the study of the adsorption of Staphylococcus K phage upon its host. Br. J. Exp. Pathol. 33:177-182.
18. Kreuger, A. P., and J. H. Northrop. 1930. The kinetics of the bacterium-bacteriophage reaction. J. Gen. Physiol. 14:223.
19. Krylov, V. N. 2001. Phage therapy in terms of bacteriophage genetics: hopes, prospects, safety, limitations. Russ. J. Genet. 37:715-730.
20. Lowy, F. D. 2003. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Investig. 111:1265-1273.
21. Matsuzaki, S., M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, T. Shuin, Y. Shen, Z. Jin, S. Fujimoto, M. D. Nasimuzzaman, H. Wakiguchi, S. Sugihara, T. Sugiura, S. Koda, A. Muraoka, and S. Imai. 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J. Infect. Dis. 187:613-624.
22. Merril, C. R., D. Scholl, and S. L. Adhya. 2003. The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov. 2:489-497.
23. Naylor, A. R., P. D. Hayes, and S. Darke. 2001. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur. J. Vasc. Endovasc. Surg. 21:289-294.
24. Noble, W. C. 1998. Staphylococcal diseases, p. 231-256. In L. Collier, A. Balows, and M. Sussman (ed.), Topley and Wilsons microbiology and microbial infections, 9th ed., vol. 3. Oxford University Press, New York, N.Y.
25. O'Flaherty, S., A. Coffey, R. Edwards, W. Meaney, G. F. Fitzgerald, and R. P. Ross. 2004. Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J. Bacteriol. 186:2862-2871.
26. O'Flynn, G., R. P. Ross, G. F. Fitzgerald, and A. Coffey. 2004. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl. Environ. Microbiol. 70:3417-3424.
27. O'Sullivan, D., D. P. Twomey, A. Coffey, C. Hill, G. F. Fitzgerald, and R. P. Ross. 2000. Novel type I restriction specificities through domain shuffling of HsdS subunits in Lactococcus lactis. Mol. Microbiol. 36:866-875.
28. Rees, P. J., and B. A. Fry. 1981. The morphology of staphylococcal bacteriophage K and DNA metabolism in infected Staphylococcus aureus. J. Gen. Virol. 53:293-307.
29. Rees, P. J., and B. A. Fry. 1981. The replication of bacteriophage K DNA in Staphylococcus aureus. J. Gen. Virol. 55:41-51.
30. Rees, P. J., and B. A. Fry. 1983. Structure and properties of the rapidly sedimenting replicating complex of staphylococcal phage K DNA. J. Gen. Virol. 64:191-198.
31. Rippon, J. E. 1956. The classification of bacteriophages lysing staphylococci. J. Hyg. 54:213-226.
32. Rountree, P. M. 1949. The serological differentiation of staphylococcal bacteriophages. J. Gen. Microbiol. 3:164-173.
33. Rubin, R. J., C. A. Harrington, A. Poon, K. Dietrich, J. A. Greene, and A. Moiduddin. 1999. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. 5:9-17.
34. Ryan, M. P., J. Flynn, C. Hill, R. P. Ross, and W. J. Meaney. 1999. The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in nonlactating dairy cows. J. Dairy Sci. 82:2108-2114.
35. Sharp, R. 2001. Bacteriophages: biology and history. J. Chem. Technol. Biotechnol. 76:667-672.
36. Sulakveidze, A., Z. Alavidze, and J. G. Morris. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
37. Tiemersma, E. W., S. L. A. M. Bronzwaer, O. Lyytikainen, J. E. Degener, P. Schrijnemakers, N. Bruinsma, J. Monen, W. Witte, H. Grundmann, and Eurpoean Antimicrobial Resistance Surveillance System Participants. 2004. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg. Infect. Dis. 10:1627-1634.
38. Twomey, D. P., A. I. Wheelock, J. Flynn, W. J. Meaney, C. Hill, and R. P. Ross. 2000. Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147. J. Dairy Sci. 83:1981-1988.